3
Events
29 April, 2021

What lessons from Covid-19 for advancing antibiotic R&D?

Global Health Centre and Suerie Moon
3
News
9th May 2023

The World Health Assembly and the Imagined Citizens of the World

Global Health Centre
3
Publications
Report, 2018

From polio eradication to global health transition the role of development and multilateral actors : meeting report Stockholm

Global Health Centre
35
News
4th February 2020

The Gender Responsiveness of Social Marketing Interventions Focused on Neglected Tropical Diseases

Claire Somerville and Gender Centre
316
News
20th August 2019

Une vie avant la recherche : “Je suis médecin avant d’être anthropologue”

Vinh-Kim Nguyen
3
Publications
Journal article, 2018

Disruptions that shape global health Author

Ilona Kickbusch
317
Research
Research project

Trends and Influences of Private Finance on Global Health Initiatives and Development Goals in Resource-constrained Countries

Global Health Centre and Ilona Kickbusch
316
Events
25 November, 2020

Monoclonal antibodies for the treatment and prevention of diseases: why and how to expand global access

Global Health Centre and Suerie Moon
Research
In progress

The Uncounted: Visibility and the Politics of Data in Global Health

Sara Davis
316
Events
15 January, 2019

Using competition law to address high medicines prices

Maison de la Paix
Global Health Centre
3
News
5th February 2020

Opening up a dialogue between reproductive technologies

Global Health Centre
3
Publications
Report, 2019

Health a political choice: delivering universal health coverage 2030

Ilona Kickbusch
Close

Goal 3 seeks to “ensure health and well-being for all, at every stage of life. The Goal addresses all major health priorities, including reproductive, maternal and child health; communicable, non-communicable and environmental diseases; universal health coverage; and access for all to safe, effective, quality and affordable medicines and vaccines. It also calls for more research and development, increased health financing, and strengthened capacity of all countries in health risk reduction and management” as the UN Sustainable Development Knowledge Platform highlights. Read more about Goal 3.

Close
Target 3.1

By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

Target 3.2

By 2030, end preventable deaths of newborns and children under 5 years of age, with all countries aiming to reduce neonatal mortality to at least as low as 12 per 1,000 live births and under-5 mortality to at least as low as 25 per 1,000 live births

Target 3.3

By 2030, end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases and combat hepatitis, water-borne diseases and other communicable diseases

Target 3.4

By 2030, reduce by one third premature mortality from non-communicable diseases through prevention and treatment and promote mental health and well-being

Target 3.5

Strengthen the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

Target 3.6

By 2020, halve the number of global deaths and injuries from road traffic accidents

Target 3.7

By 2030, ensure universal access to sexual and reproductive health-care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programmes

Target 3.8

Achieve universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all

Target 3.9

By 2030, substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water and soil pollution and contamination

Target 3.a

Strengthen the implementation of the World Health Organization Framework Convention on Tobacco Control in all countries, as appropriate

Target 3.b

Support the research and development of vaccines and medicines for the communicable and noncommunicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all

Target 3.c

Substantially increase health financing and the recruitment, development, training and retention of the health workforce in developing countries, especially in least developed countries and small island developing States

Target 3.d

Strengthen the capacity of all countries, in particular developing countries, for early warning, risk reduction and management of national and global health risks